GeneNews' Q2 Revenues Down; Cuts Net Loss

The firm significantly trimmed its R&D costs, helping the firm lower its net loss for the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories